1. at receptor antagonists u(3)Shock cardiac output个; 0 redistribution of blood flow. shift of fluid from interstitial compartment to vascular compartment; u pulmonary pressure u should be used after fully adequate replacement of intravascular fluid
(3) Shock cardiac output ; redistribution of blood flow; shift of fluid from interstitial compartment to vascular compartment; pulmonary pressure ; should be used after fully adequate replacement of intravascular fluid 1. receptor antagonists
1. at receptor antagonists d() Acute myocardial infarction and congestive heart failure after-oad↓; cardiac output个 2. CAPACITANCE Venules 3. PUMP OUTPUT CNS Sympathetic nerves 4. VOLUME 1. RESISTANCE Kidneys Arterioles Re Aldosterone-+- Angiotensin
(4) Acute myocardial infarction and congestive heart failure after-load ； cardiac output 1. receptor antagonists
1. at receptor antagonists u(5) Pheochromocytoma pre-and post-operation uses a diagnosis (6) Others: impotency(阳痿)
(5) Pheochromocytoma pre- and post-operation uses diagnosis (6) Others: impotency (阳痿) 1. receptor antagonists
1. at receptor antagonists u 1.3 Adverse effects a(1)Postural hypotension u(2) Reflex heart stimulation u tachycardia, arrhythmia, angina pectoris u 3)GI reactions u(4)Other central depression
1.3 Adverse effects (1) Postural hypotension (2) Reflex heart stimulation tachycardia, arrhythmia, angina pectoris (3) G.I. reactions (4) Other central depression 1. receptor antagonists
1. at receptor antagonists T0 lazoline妥拉唑啉 weak effects more severe adverse eftects
Tolazoline 妥拉唑啉 weak effects more severe adverse effects 1. receptor antagonists